Description:
A drug that targets the appetite control system in the brain could bring about significant weight loss in people with clinical obesity, according to new research.

Source:

https://www.sciencedaily.com/releases/2017/10/171023131955.htm

Date: October 23, 2017
University of Leeds

Journal Reference:

John Blundell, Graham Finlayson, Mads Axelsen, Anne Flint, Catherine Gibbons, Trine Kvist, Julie B. Hjerpsted. Effects of once-weekly semaglutide on appetite, energy intake, control of eating, food preference and body weight in subjects with obesity. Diabetes, Obesity and Metabolism, 2017; 19 (9): 1242 DOI: 10.1111/dom.12932